These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36853434)

  • 1. Animal Models of Childhood Exposure to Lead or Manganese: Evidence for Impaired Attention, Impulse Control, and Affect Regulation and Assessment of Potential Therapies.
    Smith DR; Strupp BJ
    Neurotherapeutics; 2023 Jan; 20(1):3-21. PubMed ID: 36853434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate alleviates cognitive dysfunction caused by early manganese exposure: Role of catecholaminergic receptors.
    Beaudin SA; Howard S; Santiago N; Strupp BJ; Smith DR
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Apr; 131():110949. PubMed ID: 38266866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal choline supplementation lessens the behavioral dysfunction produced by developmental manganese exposure in a rodent model of ADHD.
    Howard SL; Beaudin SA; Strupp BJ; Smith DR
    Neurotoxicol Teratol; 2024; 102():107337. PubMed ID: 38423398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure.
    Stangle DE; Smith DR; Beaudin SA; Strawderman MS; Levitsky DA; Strupp BJ
    Environ Health Perspect; 2007 Feb; 115(2):201-9. PubMed ID: 17384765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate alleviates cognitive dysfunction from early Mn exposure: Role of catecholaminergic receptors.
    Beaudin SA; Howard S; Santiago N; Strupp BJ; Smith DR
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scientific basis for chelation: animal studies and lead chelation.
    Smith D; Strupp BJ
    J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensorimotor dysfunction due to developmental manganese exposure is less severe in adult female than male rats and partially improved by acute methylphenidate treatment.
    Beaudin SA; Gorman S; Schilpp N; Woodfin D; Strupp BJ; Smith DR
    Neurotoxicol Teratol; 2024; 102():107330. PubMed ID: 38307398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental Manganese Exposure Causes Lasting Attention Deficits Accompanied by Dysregulation of mTOR Signaling and Catecholaminergic Gene Expression in Brain Prefrontal Cortex.
    Santiago NA; He B; Howard SL; Beaudin S; Strupp BJ; Smith DR
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate alleviates manganese-induced impulsivity but not distractibility.
    Beaudin SA; Strupp BJ; Uribe W; Ysais L; Strawderman M; Smith DR
    Neurotoxicol Teratol; 2017 May; 61():17-28. PubMed ID: 28363668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
    Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
    Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Toxicol Appl Pharmacol; 1999 Dec; 161(3):283-93. PubMed ID: 10620486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal choline supplementation lessens the behavioral dysfunction produced by developmental manganese exposure in a rodent model of ADHD.
    Howard SL; Beaudin SA; Strupp BJ; Smith DR
    bioRxiv; 2023 Oct; ():. PubMed ID: 37425833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure.
    Farias AC; Cunha A; Benko CR; McCracken JT; Costa MT; Farias LG; Cordeiro ML
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):113-8. PubMed ID: 20415606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Postnatal Manganese Exposure Causes Lasting Impairment of Selective and Focused Attention and Arousal Regulation in Adult Rats.
    Beaudin SA; Strupp BJ; Strawderman M; Smith DR
    Environ Health Perspect; 2017 Feb; 125(2):230-237. PubMed ID: 27384154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats.
    Beaudin SA; Stangle DE; Smith DR; Levitsky DA; Strupp BJ
    Neurotoxicol Teratol; 2007; 29(2):188-202. PubMed ID: 17196787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment.
    Zhu J; Zhang X; Xu Y; Spencer TJ; Biederman J; Bhide PG
    J Neurosci; 2012 Jul; 32(27):9410-8. PubMed ID: 22764249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral methylphenidate alleviates the fine motor dysfunction caused by chronic postnatal manganese exposure in adult rats.
    Beaudin SA; Strupp BJ; Lasley SM; Fornal CA; Mandal S; Smith DR
    Toxicol Sci; 2015 Apr; 144(2):318-27. PubMed ID: 25601986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder.
    Eubig PA; Aguiar A; Schantz SL
    Environ Health Perspect; 2010 Dec; 118(12):1654-67. PubMed ID: 20829149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.
    Rogan WJ; Dietrich KN; Ware JH; Dockery DW; Salganik M; Radcliffe J; Jones RL; Ragan NB; Chisolm JJ; Rhoads GG;
    N Engl J Med; 2001 May; 344(19):1421-6. PubMed ID: 11346806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.